首页> 外文期刊>海南医科大学学报(英文版) >The study of calcitriol,cinacalcet combined with nursing intervention effect of SHPT, calcium, phosphorus metabolism and parathyroid hormone on MHD patients
【24h】

The study of calcitriol,cinacalcet combined with nursing intervention effect of SHPT, calcium, phosphorus metabolism and parathyroid hormone on MHD patients

机译:骨化三醇,西那卡塞联合SHPT,钙,磷代谢和甲状旁腺激素对MHD患者的护理干预作用研究

获取原文
获取原文并翻译 | 示例
           

摘要

Objective:To investigate calcitriol, cinacalcet plus comprehensive intervention on maintenance hemodialysis (MHD) patients with secondary hyperparathyroidism (SHPT) calcium (Ca), phosphorus (P) metabolism and parathyroid hormone (PTH) effect.Methods: A total of 80 cases of patients with SHPT from January 2014 to January 2016 in our hospital were randomly divided into observation group and control group, control group to eat the whole piece of cinacalcet hydrochloride oral tablets, the initial dose of 25 mg/d, every 2 to 4 weeks, according to Ca×P, parathyroid hormone (iPTH) test results adjust the dose, the maximum dose of not more than 75 mg/d, the observation group in the control group on the basis of oral administration of Calcitriol Soft Capsules 0.25 g/d, 3 times/week, 2 groups were given comprehensive intervention measures, to evaluate the curative effect after 3 months of treatment. The 2 groups before and after treatment collected fasting peripheral venous blood, the determination of Ca, P and alkaline phosphatase by colorimetric method (ALP), Ca, P product calculation (Ca×P), to detect the level of iPTH before and after treatment by ELISA method; TY-6858-HI type ultrasound instrument, measuring length, width and thickness of the parathyroid glands, and calculate the parathyroid gland volume.Results:in the observation group after treatment, Ca, Ca×P increased degree, P, ALP, iPTH lower than the control group, the size of the parathyroid gland was better than the control group.Conclusion:calcitriol, cinacalcet combined intervention therapy has good clinical effect in patients with MHD SHPT, Ca, P can effectively improve the metabolism, reduce the level of iPTH, reduce the parathyroid gland volume is worthy of promotion.
机译:目的:探讨骨化三醇,西那卡塞加综合干预对维持性血液透析(MHD)患者继发性甲状旁腺功能亢进(SHPT)钙(Ca),磷(P)代谢和甲状旁腺激素(PTH)的影响。方法:共80例患者自2014年1月至2016年1月在我院接受SHPT治疗的患者随机分为观察组和对照组,对照组吃整片盐酸西那卡塞口服片,初始剂量为25 mg / d,每2至4周,根据对Ca×P,甲状旁腺激素(iPTH)的检测结果调整剂量,最大剂量不超过75 mg / d,观察组在对照组口服基础上给予骨化三醇软胶囊0.25 g / d,每周3次,对2组患者进行综合干预,评价治疗3个月后的疗效。两组治疗前后分别采集空腹外周血,通过比色法(ALP),钙,磷积计算(Ca×P)测定Ca,P和碱性磷酸酶,以检测治疗前后的iPTH水平ELISA法TY-6858-HI型超声仪,测量甲状旁腺的长度,宽度和厚度,并计算甲状旁腺的体积。结果:观察组在治疗后,Ca,Ca×P升高,P,ALP,iPTH降低结论:骨化三醇,西那卡塞联合干预治疗MHD SHPT,Ca,P可有效改善新陈代谢,降低iPTH水平,对甲状旁腺的影响优于对照组。 ,减少甲状旁腺的体积值得推广。

著录项

  • 来源
    《海南医科大学学报(英文版)》 |2017年第6期|45-47|共3页
  • 作者

    Le Chen; Xiao-Yun Wu;

  • 作者单位

    Department of Facial Features, Second Affiliated Hospital of Hebei North University 075100;

    Department of Renal Medicine, Second Affiliated Hospital of Hebei North University 075100;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号